21 Nov 2018

NICE Rejects Professor Mike Barnes’ Expertise in Cannabis as Medicine for a Second Time

Professor Mike Barnes is without doubt the UK clinician with the most expertise in the use of cannabis as medicine. He should have been first choice as a member of the NICE committee charged with developing cannabis prescribing guidelines and, as reported here, its rejection of his application was greeted with astonishment. However, NICE relented and invited Professor Barnes to an interview. Now they have rejected him again. Mike was responsible for obtaining the first medicinal cannabis licences for Sophia Gibson...

26 Jul 2018

The Definition Of A Cannabis-Derived Medicinal Product Must Include Standardised Herbal Cannabis Or Sajid Javid’s Reform Will Fail.

Bedrocan, the Netherlands government's official producer, grows cannabis in which the cannabinoid and terpene content is standardised and consistent. It does this by very careful cultivation techniques which include clonal propagation, continuous analysis and gamma irradiation to eliminate contamination with potentially harmful microbes. Its production facility is Good Manufacturing Practice (GMP) certified. With the exception of Sativex, which NICE has declared as not cost effective, the Bedrocan range offers the only medicinal cannabis products which could be readily available in the...

02 Apr 2018

Home Office Denies FOI Request In Cover-Up Of All Information On Cannabis Production Licences

On 6th March 2018 CLEAR submitted a Freedom of Information Request to the Home Office asking for full details of the licences accounting for the legal production of cannabis in the UK. This arose from the story which we broke on 4th March revealing that the UK is the world’s largest producer and exporter of legal cannabis, this according to data provided to the International Narcotics Control Board (INCB) by the government. The Home Office has refused the request. Its grounds...

09 Mar 2018

This is Paul Kenward, husband of Victoria Atkins MP who is the UK drugs minister. He grows cannabis for a living.

Mr Kenward is managing director of British Sugar which grows cannabis under contract to GW Pharmaceuticals at its 45 acre greenhouse in Wissington, Norfolk.  As confirmed by British Sugar, the cannabis is for production of Epidiolex, GW's epilepsy medicine which is understood to be 98% cannabidiol (CBD). Epidiolex is not yet licensed as a medicine although it is currently with the FDA for US approval and the European Medicines Agency for approval within the EU...

08 Mar 2018

Misleading Parliament Again. Victoria Atkins, The Drugs Minister With A Family Cannabis Farm.

She's back!  Victoria Atkins MP is again engaged in answering parliamentary questions on cannabis for the UK government.  Clearly this is wholly improper when she directly benefits from commercial production of cannabis. Ms Atkins disappeared from public view for a few weeks after CLEAR revealed that her husband is growing 45 acres of cannabis under government licence while she argues against drugs regulation in Parliament. It was particularly notable that she was absent from the House of Commons during the recent...

04 Mar 2018

The UK Is The World’s Largest Producer And Exporter Of Legal Cannabis But Its Citizens Are Denied Any Access At All

This is the astonishing fact revealed by the International Narcotics Control Board (INCB) in its 2017 report on narcotic drugs. In the UK no one has any legal access to any form of cannabis except exempt products derived from industrial hemp, most commonly CBD oil. Theoretically, the cannabis medicine Sativex is available but in practice, in England it is virtually impossible to obtain it except on a private prescription as the National Institute for Health and Care Excellence (NICE) has recommended that it...

31 Jan 2017

The UK Government’s Very Last Excuse For Denying Access To Medicinal Cannabis.

Essentially, UK government policy on cannabis hasn't altered since 1971.  Despite the vast amount of new evidence published since then and revolutionary change, particularly on medicinal use, all across the world, successive governments have stubbornly and obstinately refused to consider any sort of reform. It doesn't matter which party has been in power, Conservative, Labour or the coalition, it's a subject that ministers and MPs simply refuse to engage with.  It's easier that way for them and be in no doubt: laziness,...

17 Sep 2016

CLEAR’s Submission To The Parliamentary Inquiry Into Medicinal Cannabis.

This was the response that CLEAR submitted to the APPG in February 2016.  In March 2016, Roland Gyallay-Pap, then managing director of CLEAR and Peter Reynolds, president, were called to give oral evidence to the Inquiry. A PDF copy of this document may be downloaded here. A copy of the Powerpoint presentation delivered by CLEAR at the oral evidence hearing can be downloaded here.   Introduction In June 2015 the All-Party Parliamentary Group for Drug Policy Reform (APPG) published a short report arguing for a rescheduling of...

02 Sep 2016

Whose Money Is UCL Wasting On Pointless Cannabis Research?

The Times reports "Stone me: cannabis users don't like hard work" The Independent says "Getting high on cannabis makes you less likely to work hard for money, study says" The mendacious Daily Mail claims: "How just one cannabis joint harms your will to work: Fears long-term drug use could harm motivation even when not high" Utterly pointless research. Such results can be determined by common sense and experience. UCL has a habit of frittering money away on pointless research into cannabis. First of all we had...

23 Apr 2016

CLEAR and GroGlo Establish First UK Clinical Trials on Cannabis for Chronic Pain.

CLEAR has formed a partnership with the research arm of GroGlo, a UK-based manufacturer of high power, LED, horticultural grow lighting. The plan is to grow cannabis under a Home Office licence for the production of cannabis oil, both as a dietary supplement and for the development of medical products.  To begin with, a low-THC crop of industrial hemp will be planted.  We will be using the finola strain, originally developed in Finland and known for its short stature and early flowering. Unlike hemp grown for fibre, finola...